| GRCh37/hg19 position | 12:103234229 |
| GRCh38/hg38 position | 12:102840451 |
| Alleles (ref/alt) | C/T |
| dbSNP rsid | rs199475621 |
| Gene symbol |
PAH |
| Most severe consequence | missense_variant |
| Flanking sequence | ATCTTAAGCTGCTGGGTATTGTCCAAGACCT[C/T]AATCCTTTGGGTGTATGGGTCGTAGCGAACT |
| HGVS |
NM_000277.3:c.1264G>A NM_001354304.2:c.1264G>A NP_000268.1:p.Glu422Lys |
| Transcript | Gene | Exon number | Consequence | HGVS cDNA | HGVS protein | Location | Protein location | ||||
| NM_000277.3 | PAH | 13 | missense_variant | c.1264G>A | p.Glu422Lys | Exon 12 |
|
||||
| NM_001354304.2 | PAH | 14 | missense_variant | c.1264G>A | p.Glu422Lys | Exon 13 |
|
| Database | Population | AC | AN | Hom | AF |
| Tool | Score | Prediction |
|---|---|---|
| SIFT | 0.002 | damaging |
| Polyphen2 HDIV | 0.989 | probably damaging |
| Polyphen2 HVAR | 0.905 | possibly damaging |
| LRT | 0.000000 | deleterious |
| MutationTaster | 1 | disease_causing |
| MutationAssessor | 3.04 | medium |
| FATHMM | -6.3 | damaging |
| MetaSVM | 1.0375 | damaging |
| MetaLR | 0.9863 | damaging |
| PROVEAN | -3.28 | damaging |
| M-CAP | 0.713738 | damaging |
| CADD | 4.45801 | - |
| REVEL | 0.96 | - |
| Method | Score | Level |
| GERP++ | 5.33 | Conserved |
| phastCons46way primates | 0.997 | Highly conserved |
| phastCons46way placental | 1.000 | Highly conserved |
| phastCons100way vertebrates | 1.000 | Highly conserved |
| phyloP46way primates | 0.561 | Conserved |
| phyloP46way placental | 2.664 | Conserved |
| phyloP100way vertebrates | 7.049 | Conserved |
| Accession | Clinical significance | Date last evaluated | Review status | Method | Disease name | Disease symbol | Disease inheritance | Pubmed |
|---|---|---|---|---|---|---|---|---|
| RCV000088821 | not provided | . | no assertion provided | literature only | not provided | - | - | - |
| RCV001199987 | Uncertain significance | 2020-03-27 | reviewed by expert panel | curation | Phenylketonuria | PKU | Autosomal recessive inheritance |
InterVar is a software tool for clinical interpretation of genetic variants by the ACMG/AMP 2015 guideline. The eveidence tags that variant met are highlighted. Please note that evidence tags with need to be evaluated manually.
| Benign | Pathogenic | |||||
|---|---|---|---|---|---|---|
| Strong | Supporting | Supporting | Moderate | Strong | Very Strong | |
| Population data | BA1 BS1 BS2 |
PM2 | PS4 | |||
| Computational and predictive data | BP1 BP3 BP4 BP7 |
PP3 | PM4 PM5 |
PS1 | PVS1 | |
| Functional data | BS3 | PP2 | PM1 | PS3 | ||
| Segregation data | BS4 | PP1 | PP1 | PP1 | ||
| De novo data | PM6 | PS2 | ||||
| Allelic data | BP2 | PM3 | ||||
| Other database | BP6 | PP5 | ||||
| Other data | BP5 | PP4 | ||||
The physichemical property of amino acid change.
| Trait | Glu (E) | Lys (K) |
| Amino acid name | Glutamic acid | Lysine |
| Side chain class | acid | basic |
| Polarity | acidic polar | basic polar |
| Charge (pH=7.4) | negatively charged | positively chared |
| Hydropathy | hydrophilic | hydrophilic |
| Molecular weight | 147.131 | 146.189 |